Akretiv Animal Health, Inc.

Akretiv Animal Health Inc. focuses on adapting human therapeutic innovations for the expanding $80 billion animal health market. The company’s unique partnered model offers human life sciences companies a more effective alternative to traditional out-licensing by enabling them to retain greater incremental revenue and control over their intellectual property. Akretiv explores diverse areas of opportunity, maintaining a streamlined pipeline of three major programs at any time to ensure focused development and high potential returns. By fostering synergies between human and animal health industries, Akretiv creates value through translational insights, regulatory efficiency, and shared profitability. The company is seeking investors to support its mission of advancing innovative animal health solutions while delivering attractive financial outcomes.